Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls

It's been a busy couple of days for Novo Nordisk. The pharma company ($NVO) has just struck a $100 million licensing deal on new drug delivery technology as its chief scientific officer reviews potent…
Read the full story: News